Literature DB >> 22684340

Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.

Viviane M Conraads1, Emeline M Van Craenenbroeck, Catherine De Maeyer, An M Van Berendoncks, Paul J Beckers, Christiaan J Vrints.   

Abstract

Despite remarkable progress in the therapeutic approach of patients with chronic heart failure (CHF), exercise intolerance remains one of the hallmarks of the disease. During the past two decades, evidence has accumulated to underscore the key role of both endothelial dysfunction and skeletal muscle wasting in the process that gradually leads to physical incapacity. Whereas reverse ventricular remodeling has been attributed to aerobic exercise training, the vast majority of studies conducted in this specific patient population emphasize the reversal of peripheral abnormalities. In this review, we provide a general overview on underlying pathophysiological mechanisms. In addition, emphasis is put on recently identified pathways, which contribute to a deeper understanding of the main causes of exercise tolerance and the potential for reversal through exercise training. Recently, deficient bone marrow-related endothelial repair mechanisms have received considerable attention. Both acute exercise bouts, as well as exercise training, affect the mobilization of endothelial progenitor cells and their function. The observed changes following exercise training are believed to significantly contribute to improvement of peripheral endothelial function, as well as exercise capacity. With regard to skeletal muscle dysfunction and energy deprivation, adiponectin has been suggested to play a significant role. The demonstration of local skeletal muscle adiponectin resistance may provide an interesting and new link between the insulin resistant state and skeletal muscle wasting in CHF patients.

Entities:  

Mesh:

Year:  2013        PMID: 22684340     DOI: 10.1007/s10741-012-9324-0

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  100 in total

1.  Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.

Authors:  Ulrich Laufs; Nikos Werner; Andreas Link; Matthias Endres; Sven Wassmann; Kristina Jürgens; Eckart Miche; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2003-12-22       Impact factor: 29.690

2.  Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure.

Authors:  V Adams; J Yu; S Möbius-Winkler; A Linke; C Weigl; L Hilbrich; G Schuler; R Hambrecht
Journal:  Biochem Mol Med       Date:  1997-08

Review 3.  Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway.

Authors:  Bert R Everaert; Emeline M Van Craenenbroeck; Vicky Y Hoymans; Steven E Haine; Luc Van Nassauw; Viviane M Conraads; Jean-Pierre Timmermans; Christiaan J Vrints
Journal:  Int J Cardiol       Date:  2010-05-04       Impact factor: 4.164

4.  Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects.

Authors:  B Mettauer; J Zoll; H Sanchez; E Lampert; F Ribera; V Veksler; X Bigard; P Mateo; E Epailly; J Lonsdorfer; R Ventura-Clapier
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

5.  Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle.

Authors:  Anne Garnier; Dominique Fortin; Joffrey Zoll; Benoit N'Guessan; Bertrand Mettauer; Eliane Lampert; Vladimir Veksler; Renée Ventura-Clapier
Journal:  FASEB J       Date:  2005-01       Impact factor: 5.191

6.  Evidence for adipose-muscle cross talk: opposing regulation of muscle proteolysis by adiponectin and Fatty acids.

Authors:  Qiugen Zhou; Jie Du; Zhaoyong Hu; Kenneth Walsh; Xiaonan H Wang
Journal:  Endocrinology       Date:  2007-08-30       Impact factor: 4.736

Review 7.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

8.  Exercise training reduces circulating adiponectin levels in patients with chronic heart failure.

Authors:  An M Van Berendoncks; Paul Beckers; Vicky Y Hoymans; Nadine Possemiers; Floris L Wuytss; Christiaan J Vrints; Viviane M Conraads
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

9.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

10.  Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia.

Authors:  Gerasimos S Filippatos; Christos Kanatselos; Dimitris D Manolatos; Bill Vougas; Anthony Sideris; Dimitra Kardara; Stefan D Anker; Fotios Kardaras; Bruce Uhal
Journal:  Int J Cardiol       Date:  2003-07       Impact factor: 4.164

View more
  16 in total

1.  Circulating Adiponectin Levels Following Treatment Can Predict Late Clinical Outcomes in Chronic Heart Failure.

Authors:  Ho-Ping Yu; Hsu-Lung Jen; Wei-Hsian Yin; Jeng Wei
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

2.  Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

Authors:  Nikole J Byrne; Jody Levasseur; Miranda M Sung; Grant Masson; Jamie Boisvenue; Martin E Young; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2016-03-10       Impact factor: 10.787

3.  Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.

Authors:  Osamu Seguchi; Tomoyuki Fujita; Yoshihiro Murata; Haruki Sunami; Takuma Sato; Takuya Watanabe; Seiko Nakajima; Kensuke Kuroda; Eriko Hisamatsu; Takamasa Sato; Masanobu Yanase; Hiroki Hata; Kyoichi Wada; Hatsue Ishibashi-Ueda; Junjiro Kobayashi; Takeshi Nakatani
Journal:  Heart Vessels       Date:  2015-02-15       Impact factor: 2.037

4.  Maximal oxygen uptake and exercise tolerance are improved in rats with heart failure subjected to low-level laser therapy associated with resistance training.

Authors:  Vítor Scotta Hentschke; Lucas Capalonga; Douglas Dalcin Rossato; Júlia Luíza Perini; Jadson Pereira Alves; Giuseppe Potrick Stefani; Marlus Karsten; Mauro Pontes; Pedro Dal Lago
Journal:  Lasers Med Sci       Date:  2016-11-17       Impact factor: 3.161

5.  Effects of nitrite infusion on skeletal muscle vascular control during exercise in rats with chronic heart failure.

Authors:  Angela A Glean; Scott K Ferguson; Clark T Holdsworth; Trenton D Colburn; Jennifer L Wright; Alex J Fees; Karen S Hageman; David C Poole; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-14       Impact factor: 4.733

6.  β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure.

Authors:  Satoshi Masutani; Heng-Jie Cheng; Atsushi Morimoto; Hiroshi Hasegawa; Qing-Hua Han; William C Little; Che Ping Cheng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

7.  C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.

Authors:  Tiankai Li; Heng-Jie Cheng; Nobuyuki Ohte; Hiroshi Hasegawa; Atsushi Morimoto; David M Herrington; William C Little; Weimin Li; Che Ping Cheng
Journal:  J Pharmacol Exp Ther       Date:  2016-03-29       Impact factor: 4.030

Review 8.  [Cardiac rehabilitation in heart failure].

Authors:  Johann Altenberger
Journal:  Wien Med Wochenschr       Date:  2017-10-02

9.  Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.

Authors:  Lin Yan; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-05       Impact factor: 4.733

Review 10.  Exercise Training in Heart Failure Patients With Persistent Atrial Fibrillation: a Practical Approach.

Authors:  Justien Cornelis; Jonathan Myers; Hein Heidbuchel; Christiaan Vrints; Paul Beckers
Journal:  Card Fail Rev       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.